Joint venture

W&T Offshore Announces Fourth Quarter and Full Year 2023 Results Including Year-End 2023 Proved Reserves, Provides Guidance for 2024, and Declares Dividend for First Quarter of 2024

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, Production, Senior, Depreciation, Holy Grail, Balance sheet, Joint venture, ARO, Free cash flow, Natural gas, Cost, Term loan, Debt, British thermal unit, Capital expenditure, Table, Transport, NGL, TTM, Atlas, GAAP, Comparable, Bankruptcy, GOM, LOE, Policy, Tax, Public expenditure, Investment, Hand, G&A, Oil

Detailed guidance for the first quarter of 2024 and full year 2024 was also provided, and W&T announced its dividend for the first quarter of 2024.

Key Points: 
  • Detailed guidance for the first quarter of 2024 and full year 2024 was also provided, and W&T announced its dividend for the first quarter of 2024.
  • We remain committed to enhancing shareholder value and returning value to our shareholders through the quarterly dividend announced in November 2023.
  • The W&T year-end 2023 proved reserves do not include the 18.7 MMBoe of proved reserves acquired in early January 2024 for $72 million.
  • W&T’s reserve life ratio at year-end 2023, based on year-end 2023 proved reserves and 2023 production, was 9.7 years.

Leveraging A.I. for Retail Business Expected to Drive the Market Size to $38 Billion by 2029

Retrieved on: 
Wednesday, February 21, 2024
Cloud, Investment, Growth, Commerce, VMware, Salesforce, Amazon (company), Google Cloud, OTCQB, DRIVE, Nvidia, QPU, Joint venture, VMW, Vodafone, MSFT, AMZN, GPU, SME, Microsoft, Machine learning, NVDA, Environment, Partnership, Computer, Library, GOOG, Artificial intelligence, NVIDIA, PALM, Internet, USD, AI, Intelligence, Cloud database, Internet of things, Government, Press release, Organization, PostgreSQL, Deep learning, CPU, Video game

A recent report from Mordor Intelligence said that: “AI in retail is undergoing significant transformations with the integration of Retail AI.

Key Points: 
  • A recent report from Mordor Intelligence said that: “AI in retail is undergoing significant transformations with the integration of Retail AI.
  • Companies are leveraging Artificial Intelligence in Retail to enhance strategies, improve outcomes, and boost online customer engagement.
  • The use of AI Retail Technology is expected to surge, with investments in AI-Powered Retail analytics increasing.” It projected that the AI in Retail Business Market size is estimated at USD 9.65 billion in 2024, and is expected to reach USD 38.92 billion by 2029, growing at a CAGR of 32.17% during the forecast period (2024-2029).
  • The report added: “The sector is changing due to the introduction of artificial intelligence in retail.

Silver Spike Investment Corp. Announces Agreement to Acquire Loan Portfolio From Chicago Atlantic

Retrieved on: 
Tuesday, February 20, 2024
Silver, Joint venture, SSC, Investment, CALP, Keefe, Bruyette & Woods, NII, LLP, Cannabis, Research, Financial services

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. (the “Company”) (Nasdaq: SSIC), a specialty finance company that has elected to be treated as a business development company, today announced that it entered into a definitive agreement with Chicago Atlantic Loan Portfolio, LLC (“CALP”) for the purchase (the “Loan Portfolio Acquisition”) from CALP of a sizeable portfolio of loans (the “CALP Loan Portfolio”).

Key Points: 
  • NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. (the “Company”) (Nasdaq: SSIC), a specialty finance company that has elected to be treated as a business development company, today announced that it entered into a definitive agreement with Chicago Atlantic Loan Portfolio, LLC (“CALP”) for the purchase (the “Loan Portfolio Acquisition”) from CALP of a sizeable portfolio of loans (the “CALP Loan Portfolio”).
  • CALP has agreed to use reasonable best efforts to add 4 loans with an aggregate value of approximately $43 million to the CALP Loan Portfolio prior to the closing of the Loan Portfolio Acquisition.
  • The Company and CALP may also agree to the addition of other loans to the CALP Loan Portfolio prior to the closing of the Loan Portfolio Acquisition.
  • The Loan Portfolio Acquisition would reduce the sector concentration of the Company’s investment portfolio, as the Company would acquire loans to both cannabis and non-cannabis companies consistent with its broadened investment strategy.

Holiday Island Holdings, Inc. Secures a Letter of Intent to Enter Into a Joint Venture With a Highly Experienced International Oil Company to Drill for Oil in Texas

Retrieved on: 
Tuesday, February 20, 2024
Letter, Marketing, Joint venture, OTC, Oil, Life, JV

PLANT CITY, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Holiday Island Holdings, Inc., dba EP3OIL, (OTC: HIHI) – operating in the Secondary Recovery of Oil & Gas Industry – has accepted a Letter of Intent to enter into a Joint Venture wherein it will receive $2.5 million from a highly experienced international oil company - Supeca Oil -  to develop the Drummond Oil Field located in West Texas.

Key Points: 
  • PLANT CITY, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Holiday Island Holdings, Inc., dba EP3OIL, (OTC: HIHI) – operating in the Secondary Recovery of Oil & Gas Industry – has accepted a Letter of Intent to enter into a Joint Venture wherein it will receive $2.5 million from a highly experienced international oil company - Supeca Oil -  to develop the Drummond Oil Field located in West Texas.
  • Projections on this field, as reported by Benchmark Petroleum Partners, indicated a significant increase in gross revenue of oil production over its life.
  • EP3OIL and Supeca Oil will perform due diligence over the next 30 days to solidify their Joint Venture.
  • Holiday Island Holdings, Inc. is committed to keeping both shareholders and the public informed on all of our opportunities and developments.

Mercedes-Benz Financial Services Canada Corporation appoints Brian Stevens as new President and CEO

Retrieved on: 
Tuesday, March 5, 2024
Professional Services, Automotive, Automotive Manufacturing, Other Automotive, Manufacturing, Finance, CFO, CPA, Structured finance, Multimedia, Joint venture, Athlon, Digital, Mercedes-Benz Group, Comptroller, MBM, EQ, Mercedes-Benz, Ernst & Young, Mercedes-Benz Bank, Duke University, Benelux, LLP, Mobility, Controller, Mercedes-Benz Mobility, Insurance, FREE, Grand Valley State University, DCS

Mercedes-Benz Financial Services Canada Corporation (MBFS), a leading automotive financial services provider and a Mercedes-Benz Mobility AG (MBM) company, is pleased to announce the appointment of Brian Stevens as its new President and CEO as of the fourth quarter 2023.

Key Points: 
  • Mercedes-Benz Financial Services Canada Corporation (MBFS), a leading automotive financial services provider and a Mercedes-Benz Mobility AG (MBM) company, is pleased to announce the appointment of Brian Stevens as its new President and CEO as of the fourth quarter 2023.
  • View the full release here: https://www.businesswire.com/news/home/20240304532618/en/
    Brian Stevens, President and CEO, Mercedes-Benz Financial Services Canada Corporation (Photo: Business Wire)
    In this role, he will lead the Canadian operations of MBM in succession of James Ryan, who was appointed CEO of Mercedes-Benz Financial Services BeNeLux, leading MBM operations in the Belgium, Netherlands and Luxembourg markets, last year.
  • "Brian brings more than a decade of experience with the Canadian market following his successful tenure as Chief Financial Officer of MBM NA.
  • Mercedes-Benz Financial Services Canada at a glance:
    Mercedes-Benz Financial Services Canada Corporation, located in Mississauga, Ontario, supports the sales efforts of Mercedes-Benz passenger cars and vans in Canada by offering premier financial services to retail customers and the dealer network.

CG Power and Industrial Solutions Limited, Renesas, and Stars Microelectronics, to Jointly Build Outsourced Semiconductor Assembly and Test Facility in India

Retrieved on: 
Friday, March 1, 2024
Technology, Semiconductor, Engineering, Manufacturing, Software, Networks, Internet, Hardware, IOT (Internet of Things), JVA, INR, Joint venture, Renesas Electronics, FC, Growth, Executive Committee, QFP, QFN, Union Council of Ministers, Murugappa Group, JV, Ecosystem, Public, Partnership

The JV brings together unique capabilities of the partners with a vision to “Make in India for the World.” CG, with around 86 years of manufacturing expertise, is keen to build semiconductor capabilities and ecosystem in India.

Key Points: 
  • The JV brings together unique capabilities of the partners with a vision to “Make in India for the World.” CG, with around 86 years of manufacturing expertise, is keen to build semiconductor capabilities and ecosystem in India.
  • Renesas, a leading semiconductor company headquartered in Japan, will provide advanced semiconductor technology and expertise.
  • The JV will be 92.3% owned by CG, with Renesas and Stars Microelectronics each holding equity capital of approximately 6.8% and 0.9%, respectively.
  • Commenting on this new venture, Mr. S. Vellayan, Chairman, CG Power and Industrial Solutions Limited, said, “CG’s entry into the semiconductor manufacturing marks a strategic diversification for us.

Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

Retrieved on: 
Thursday, February 22, 2024
Software, Professional Services, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Genetics, Health Technology, Data Analytics, Biotechnology, FDA, Health, ASPS, Acquisition, Joint venture, PMA, Forecasting, Marketing, Growth, CRC, LDT, GAAP, Webcast, Net, Helmy Eltoukhy, Research, Depreciation, Shield, Pharmaceutical industry

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and full year ended December 31, 2023.

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and full year ended December 31, 2023.
  • Development services and other revenue was $12.9 million for the fourth quarter of 2023, compared to $13.1 million for the corresponding prior year period.
  • Precision oncology gross margin was 60% in the fourth quarter of 2023, as compared to 62% in the prior year period.
  • Guardant Health will host a conference call to discuss the fourth quarter and full year 2023 financial results after market close on Thursday, February 22, 2024 at 1:30 pm Pacific Time / 4:30 pm Eastern Time.

Chicago Atlantic Enters into Joint Venture with Silver Spike

Retrieved on: 
Tuesday, February 20, 2024
REIT, Finance, Consulting, Professional Services, Construction & Property, Silver, Joint venture, SSC, IPO, SSIC, Real estate investment trust, Atlantic Ocean

Chicago Atlantic BDC Holdings, LLC and its affiliates (Chicago Atlantic) today entered into a definitive agreement with Silver Spike Capital, LLC (SSC), the investment adviser of Silver Spike Investment Corp (NASDAQ: SSIC), pursuant to which a joint venture between Chicago Atlantic and SSC would be created to combine and jointly operate SSC’s and a portion of Chicago Atlantic’s investment management businesses, subject to certain SSIC stockholder approvals and customary closing conditions (the “Joint Venture”).

Key Points: 
  • Chicago Atlantic BDC Holdings, LLC and its affiliates (Chicago Atlantic) today entered into a definitive agreement with Silver Spike Capital, LLC (SSC), the investment adviser of Silver Spike Investment Corp (NASDAQ: SSIC), pursuant to which a joint venture between Chicago Atlantic and SSC would be created to combine and jointly operate SSC’s and a portion of Chicago Atlantic’s investment management businesses, subject to certain SSIC stockholder approvals and customary closing conditions (the “Joint Venture”).
  • Upon closing of the Joint Venture, SSIC would be renamed Chicago Atlantic BDC, Inc. and SSC would be renamed Chicago Atlantic BDC Advisers, LLC.
  • The transaction follows the initial public offering and listing of the shares of Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) in 2021.
  • “This transaction is an accretive opportunity that has the potential to benefit shareholders as well as the Chicago Atlantic and Silver Spike team members,” said John Mazarakis, Chicago Atlantic Founding Partner and Executive Chairman of REFI.

DIGITIMES Asia: Why TSMC may have different strategies in Japan and Arizona? Q&A with former TSMC General Counsel Richard Thurston

Retrieved on: 
Tuesday, February 27, 2024
IDM, Well, CHIPS, Online, Senior, Investment, Culture, Government, TSMC, METI, Apple, Angstrom, Workforce, CMOS, Fujitsu, Joint venture, Principal, TI, Renesas Electronics, AMD, Federal, Suggestion, State, Interview, SSMC, Multimedia, Foot, General counsel, Bleeding, Attitude, Research, Sony, Chartered Semiconductor Manufacturing, Friends, IBM, Samsung, Texas Instruments, Communication, MediaTek, UMC, MOTIE, Politics, Semiconductor

Based on your experience in Japan and your work at TSMC, why is semiconductor manufacturing so successful in this part of Asia?

Key Points: 
  • Based on your experience in Japan and your work at TSMC, why is semiconductor manufacturing so successful in this part of Asia?
  • In Japan, pure-play foundries have not yet been successful, and making this business model work in Japan will be challenging.
  • Therefore, I've been in a unique position to observe the successful development of the semiconductor industry in these Asian countries.
  • Online Forum - TSMC Sparks Semiconductor Renaissance in Japan:
    Delve into "TSMC Sparks Semiconductor Renaissance in Japan" at our GeoWatch Webinar.

Oramed Letter to Shareholders

Retrieved on: 
Tuesday, February 20, 2024
Acquisition, Senior, Letter, Joint venture, Investment, Marketing, FDA, Hemorrhoid, Note, Herpes labialis, Wart, JV, BMI, License, Patient, Pruritus ani, Anal, Body mass index, Failure, Glycated hemoglobin, Partnership, Pharmaceutical industry

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today issued a Letter to Shareholders from its President and Chief Executive Officer, Nadav Kidron.

Key Points: 
  • NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today issued a Letter to Shareholders from its President and Chief Executive Officer, Nadav Kidron.
  • I am pleased to share with you an update regarding Oramed.
  • Oramed and HTIT Joint Venture:
    In January 2024, Oramed entered into a definitive agreement with HTIT, marking a milestone in the creation of a joint venture ("JV"), centered around Oramed's cutting-edge oral drug delivery technology.
  • We thank you for your support and look forward to keeping our shareholders updated on the important milestones ahead.